TraCS Tales of Translation features experienced scientists from academia and industry discussing the many twists and turns that are a part of research careers in the life sciences. Participating scientists will be asked to speak informally about their career decisions and pivot points, what translation means to them, and their advice for early stage researchers. This week's researcher is Daniel C. Kemp, PhD, DABT.

Kemp currently leads cross-functional teams delivering strategic design and development activities to Phase I/II drug development. Kemp has held positions of increasing responsibility in the pharmaceutical, biotechnology and CRO sectors with more than 16 yrs experience in development of regulatory strategy and development plans with direct regulatory agency interaction.

There will be a Q&A session at the end.